Related Experiment Video
Updated: Oct 16, 2026

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
Primer: Human T-cell leukemia virus type 1 (HTLV-1)
Charles R M Bangham1, Masao Matsuoka2,3
1Imperial College London, London, United Kingdom.
Abstract:
The human T-cell leukemia virus HTLV-1-also known as human T-lymphotropic virus type 1-was the first human retrovirus discovered. Unlike HIV-1, it has been present in humans for tens of thousands of years, and in consequence HTLV-1 is exquisitely adapted to persist in the individual host. Its life history therefore differs fundamentally from that of HIV-1 in key respects. HTLV-1 causes an aggressive hematological malignancy known as adult T-cell leukemia-lymphoma (ATL) and a progressive inflammatory disease of the central nervous system, HTLV-1-associated myelopathy (HAM), in a proportion of infected people. These conditions impose a significant health burden in countries where the virus is endemic.

